Declining immune responsiveness with age may be driven by changes in immune cells — not by inflammation, as previously ...

Leukon Therapeutics, Inc., a San Diego-based clinical-stage biotechnology company developing next-generation mRNA-based immunotherapies, announced new clinical results from the ongoing first-in-human ...

"Solid tumors are often difficult to treat because the immune system within the tumor gets switched off," said Michelle H. Nelson, PhD, Director of Immunobiology at Aptevo. "APVO451 is designed to ...

Scientists have unveiled a groundbreaking preliminary atlas charting the intricate development of brain cells from early ...

The study reveals how hair pigment stem cells respond to DNA damage by making fate decisions that can result in either hair graying or the development of melanoma. Throughout life, our cells face ...

There is an amended and restated offering document dated October 28, 2025, related to the Offering that can be accessed under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s ...

“When the gut is healthy and balanced, it sends ‘good’ signals that support brain health. But when it’s disturbed—by stress, poor diet, or antibiotics—it can send “stress” signals that may impair ...

Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have been awarded three multi-year grants totaling $6 million ...

Background Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by thrombosis, pregnancy ...

Current therapies such as biological DMARDs showed promising results in treating rheumatoid arthritis patients, and market penetration is expected to be more in the future and expected to drive market ...